KRAS and pancreatic neoplasm: Ramakrishnan et al. showed that for pancreatic ductal adenocarcinoma patients who tested wild type for KRAS, inactivation of the NF1 gene played a vital role in oncogenesis by triggering acinar-to-ductal metaplasia and pancreatic cancer development in situ [25].